Perspective: Fabrication of Integrated Organ-on-a-chip Via Bioprinting
Overview
Authors
Affiliations
Organ-on-a-chip has emerged as a powerful platform with widespread applications in biomedical engineering, such as pathology studies and drug screening. However, the fabrication of organ-on-a-chip is still a challenging task due to its complexity. For an integrated organ-on-a-chip, it may contain four key elements, i.e., a microfluidic chip, live cells/microtissues that are cultured in this chip, components for stimulus loading to mature the microtissues, and sensors for results readout. Recently, bioprinting has been used for fabricating organ-on-a-chip as it enables the printing of multiple materials, including biocompatible materials and even live cells in a programmable manner with a high spatial resolution. Besides, all four elements for organ-on-a-chip could be printed in a single continuous procedure on one printer; in other words, the fabrication process is assembly free. In this paper, we discuss the recent advances of organ-on-a-chip fabrication by bioprinting. Light is shed on the printing strategies, materials, and biocompatibility. In addition, some specific bioprinted organs-on-chips are analyzed in detail. Because the bioprinted organ-on-a-chip is still in its early stage, significant efforts are still needed. Thus, the challenges presented together with possible solutions and future trends are also discussed.
Breaking the mold: 3D cell cultures reshaping the future of cancer research.
Cordeiro S, Oliveira B, Valente R, Ferreira D, Luz A, Baptista P Front Cell Dev Biol. 2024; 12:1507388.
PMID: 39659521 PMC: 11628512. DOI: 10.3389/fcell.2024.1507388.
Developing organs-on-chips for biomedical applications.
Sun L, Chen H, Xu D, Liu R, Zhao Y Smart Med. 2024; 3(2):e20240009.
PMID: 39188702 PMC: 11236011. DOI: 10.1002/SMMD.20240009.
Physicochemical parameters that underlie inkjet printing for medical applications.
Azizi Machekposhti S, Movahed S, Narayan R Biophys Rev (Melville). 2024; 1(1):011301.
PMID: 38505627 PMC: 10903396. DOI: 10.1063/5.0011924.
Wang Y, Yung P, Lu G, Liu Y, Ding C, Mao C Adv Mater. 2024; 37(2):e2401334.
PMID: 38491868 PMC: 11733728. DOI: 10.1002/adma.202401334.
Novel Approaches to Studying SLC13A5 Disease.
Beltran A Metabolites. 2024; 14(2).
PMID: 38392976 PMC: 10890222. DOI: 10.3390/metabo14020084.